Predictors of fatigue in obstructive sleep apnea

Sleep Breath. 2008 Nov;12(4):397-9. doi: 10.1007/s11325-008-0192-8. Epub 2008 May 31.

Abstract

Objective: The objective of this study was to determine potential inflammatory predictors of fatigue in obstructive sleep apnea (OSA).

Materials and methods: Fifty-six women and men untreated OSA patients had their sleep monitored with polysomnography. Fatigue was assessed by the Multidimensional Fatigue Symptom Inventory-Short Form. Depressed mood was assessed by the Center for Epidemiologic Studies-Depression Scale. Blood was drawn to assess circulating levels of Interleukin-6 (IL-6) and soluble tumor necrosis factor receptor I (sTNF-RI). Age, gender, body mass index (BMI), blood pressure, OSA severity, depressed mood, and inflammatory biomarkers were entered into a hierarchical multiple linear regression analysis predicting self-reported fatigue.

Results: Approximately 42% of the patients reported significant amounts of fatigue. Higher BMI (p = 0.014), greater depressed mood (p = 0.004), and higher sTNF-RI levels (p = 0.033) were independent predictors of fatigue in the final model (full model R2 = .571; p = .003). Age, gender, blood pressure and apnea severity were unrelated to fatigue.

Conclusion: The findings suggest that in addition to depressed mood, fatigue in OSA may be associated with increased body weight and elevated levels of the proinflammatory cytokine receptor sTNF-RI. The findings support a linkage between the widely reported fatigue in OSA and a sleep-related component of inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Depression / diagnosis*
  • Fatigue / etiology*
  • Fatigue / immunology
  • Female
  • Humans
  • Interleukin-6 / blood*
  • Male
  • Middle Aged
  • Polysomnography
  • Receptors, Tumor Necrosis Factor, Type I / blood*
  • Sleep Apnea, Obstructive / diagnosis*
  • Sleep Apnea, Obstructive / immunology

Substances

  • Interleukin-6
  • Receptors, Tumor Necrosis Factor, Type I